Multiple primary tumours: challenges and approaches, a review
- PMID: 28761745
- PMCID: PMC5519797
- DOI: 10.1136/esmoopen-2017-000172
Multiple primary tumours: challenges and approaches, a review
Abstract
When in a patient more than one tumour in the same or a different organ is diagnosed, multiple primary tumours may be present. For epidemiological studies, different definitions of multiple primaries are used with the two main definitions coming from the project Surveillance Epidemiology and End Results and the International Association of Cancer Registries and International Agency for Research on Cancer. The differences in the two definitions have to be taken into consideration when reports on multiple primaries are analysed. In this review, the literature on multiple primaries is reviewed and summarised. Overall, the frequency of multiple primaries is reported in the range of 2-17%. Aetiological factors that may predispose patients to multiple primaries can be grouped into host related, lifestyle factors and environmental influences. Some of the most common cancer predisposition syndromes based on a clinical presentation are discussed and the relevant genetic evaluation and testing are characterised. Importantly, from a clinical standpoint, clinical situations when multiple primaries should be suspected and ruled out in a patient are discussed. Furthermore, general principles and possible treatment strategies for patients with synchronous and metachronous multiple primary tumours are highlighted.
Keywords: Multiple primary cancer; epidemiology; genetic predisposition; multiple primaries; second cancer; secondary primary.
Conflict of interest statement
Competing interests: AO: advisory role (compensated, institutional): Astellas, Bayer, Sanofi, Roche, Janssen. Research support (institutional): Teva, Janssen. Travel support: Astellas, Bayer, Sanofi, Roche. SS: advisory role (compensated institutional): Böhringer Ingelheim, BMS. AV, KH, HF, CH and TC report no competing interests.
Similar articles
-
Multiple Primary Tumors Over a Lifetime.Oncology (Williston Park). 2019 Jul 16;33(7):629384. Oncology (Williston Park). 2019. PMID: 31365752 Review.
-
Women with multiple primary breast cancers diagnosed within a five year period, 1994-1998.Breast Cancer Res Treat. 2005 Apr;90(3):223-32. doi: 10.1007/s10549-004-4258-4. Breast Cancer Res Treat. 2005. PMID: 15830135
-
Multiple neoplasms, single primaries, and patient survival.Cancer Manag Res. 2014 Mar 5;6:119-34. doi: 10.2147/CMAR.S57378. eCollection 2014. Cancer Manag Res. 2014. PMID: 24623992 Free PMC article.
-
Multiple primaries in pancreatic cancer patients: indicator of a genetic predisposition?Int J Epidemiol. 2000 Dec;29(6):999-1003. doi: 10.1093/ije/29.6.999. Int J Epidemiol. 2000. PMID: 11101540
-
Double resection for patients with pancreatic cancer and a second primary renal cell cancer.Dig Surg. 2003;20(5):428-32. doi: 10.1159/000072711. Epub 2003 Jul 31. Dig Surg. 2003. PMID: 12900534 Review.
Cited by
-
Use of multikinase inhibitors/lenvatinib in patients with synchronous/metachronous cancers coinciding with radioactive-resistant differentiated thyroid cancer.Cancer Med. 2022 Oct;11 Suppl 1(Suppl 1):26-32. doi: 10.1002/cam4.5107. Cancer Med. 2022. PMID: 36202607 Free PMC article. Review.
-
Incidental early diagnosis of biphasic pulmonary blastoma in a patient with history of stage IV lung adenocarcinoma.Thorac Cancer. 2020 Oct;11(10):3029-3033. doi: 10.1111/1759-7714.13629. Epub 2020 Aug 24. Thorac Cancer. 2020. PMID: 32833349 Free PMC article.
-
How to prioritize treatment in dual malignancy: A case report of patient with non-Hodgkin lymphoma and breast cancer.Ann Med Surg (Lond). 2022 Jul 31;81:104300. doi: 10.1016/j.amsu.2022.104300. eCollection 2022 Sep. Ann Med Surg (Lond). 2022. PMID: 36147133 Free PMC article.
-
Metachronous Sporadic Sextuple Primary Malignancies Including Bilateral Breast Cancers.J Breast Cancer. 2020 Aug;23(4):438-446. doi: 10.4048/jbc.2020.23.e21. J Breast Cancer. 2020. PMID: 32908793 Free PMC article.
-
Cancer Prevention for Survivors: Incidence of Second Primary Cancers and Sex Differences-A Population-Based Study from an Italian Cancer Registry.Int J Environ Res Public Health. 2022 Sep 26;19(19):12201. doi: 10.3390/ijerph191912201. Int J Environ Res Public Health. 2022. PMID: 36231502 Free PMC article.
References
-
- American Cancer Society. Cancer facts & figures 2016. 2016 Atlanta: American Cancer Society, 2016.
-
- Owen LJ. Multiple malignant neoplasms. JAMA 1921;76:1329–33.
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources